Deutsche Bank
EVH icon

Deutsche Bank’s Evolent Health EVH Stock Holding History

Deutsche Bank’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$343K Sell
150,246
-536,319
-78% -$1.7M ﹤0.01% 2765
2025
Q4 		$2.75M Buy
686,565
+585,631
+580% +$3.26M ﹤0.01% 1619
2025
Q3 		$854K Buy
100,934
+10,483
+12% +$102K ﹤0.01% 2261
2025
Q2 		$1.02M Sell
90,451
-74,985
-45% -$689K ﹤0.01% 2082
2025
Q1 		$1.57M Sell
165,436
-20,181
-11% -$204K ﹤0.01% 1899
2024
Q4 		$2.09M Buy
185,617
+32,904
+22% +$578K ﹤0.01% 1822
2024
Q3 		$4.32M Buy
152,713
+13,798
+10% +$356K ﹤0.01% 1338
2024
Q2 		$2.66M Buy
138,915
+32,617
+31% +$833K ﹤0.01% 1505
2024
Q1 		$3.49M Buy
106,298
+4,619
+5% +$147K ﹤0.01% 1414
2023
Q4 		$3.36M Buy
101,679
+3,723
+4% +$105K ﹤0.01% 1426
2023
Q3 		$2.67M Buy
97,956
+7,188
+8% +$200K ﹤0.01% 1244
2023
Q2 		$2.75M Buy
90,768
+21,828
+32% +$706K ﹤0.01% 1474
2023
Q1 		$2.24M Buy
68,940
+16,780
+32% +$531K ﹤0.01% 1628
2022
Q4 		$1.46M Buy
52,160
+5,763
+12% +$165K ﹤0.01% 1830
2022
Q3 		$1.67M Sell
46,397
-8,448
-15% -$298K ﹤0.01% 1702
2022
Q2 		$1.68M Sell
54,845
-3,597
-6% -$105K ﹤0.01% 1862
2022
Q1 		$1.89M Sell
58,442
-11,774
-17% -$308K ﹤0.01% 1940
2021
Q4 		$1.94M Buy
70,216
+3,304
+5% +$94.8K ﹤0.01% 2012
2021
Q3 		$2.08M Buy
66,912
+1,503
+2% +$36.1K ﹤0.01% 2065
2021
Q2 		$1.38M Buy
65,409
+1,001
+2% +$20K ﹤0.01% 2571
2021
Q1 		$1.3M Buy
64,408
+967
+2% +$18.4K ﹤0.01% 2499
2020
Q4 		$1.02M Buy
63,441
+19,599
+45% +$259K ﹤0.01% 2432
2020
Q3 		$545K Sell
43,842
-11,912
-21% -$140K ﹤0.01% 2592
2020
Q2 		$397K Sell
55,754
-113,959
-67% -$763K ﹤0.01% 2774
2020
Q1 		$921K Sell
169,713
-112,959
-40% -$1.01M ﹤0.01% 2131
2019
Q4 		$2.56M Sell
282,672
-126,000
-31% -$1.02M ﹤0.01% 1817
2019
Q3 		$2.94M Sell
408,672
-608,833
-60% -$4.37M ﹤0.01% 1697
2019
Q2 		$8.09M Buy
1,017,505
+370,905
+57% +$4.39M ﹤0.01% 1505
2019
Q1 		$8.13M Buy
646,600
+394,744
+157% +$6.25M ﹤0.01% 1516
2018
Q4 		$5.02M Sell
251,856
-186,770
-43% -$4.32M ﹤0.01% 1769
2018
Q3 		$12.5M Buy
438,626
+56,196
+15% +$1.34M 0.01% 1466
2018
Q2 		$8.05M Buy
382,430
+57,916
+18% +$1.1M ﹤0.01% 1926
2018
Q1 		$4.62M Sell
324,514
-122,678
-27% -$1.76M ﹤0.01% 2284
2017
Q4 		$5.5M Buy
447,192
+71,690
+19% +$1.01M ﹤0.01% 1960
2017
Q3 		$6.68M Sell
375,502
-6,501
-2% -$134K ﹤0.01% 1726
2017
Q2 		$9.68M Buy
382,003
+101,391
+36% +$2.44M 0.01% 1429
2017
Q1 		$6.26M Buy
280,612
+143,266
+104% +$2.75M ﹤0.01% 1547
2016
Q4 		$2.03M Sell
137,346
-28,034
-17% -$552K ﹤0.01% 2252
2016
Q3 		$4.07M Buy
165,380
+60,879
+58% +$1.42M ﹤0.01% 1877
2016
Q2 		$2M Sell
104,501
-79,850
-43% -$1.1M ﹤0.01% 2391
2016
Q1 		$1.95M Buy
184,351
+93,630
+103% +$967K ﹤0.01% 2384
2015
Q4 		$1.1M Buy
90,721
+10
+0% +$147 ﹤0.01% 2811
2015
Q3 		$1.45M Buy
90,711
+26,951
+42% +$526K ﹤0.01% 2698
2015
Q2 		$1.24M Buy
+63,760
New +$1.19M ﹤0.01% 2828

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank's EVH Position: Q1 2026 in Review

Deutsche Bank reduced its Evolent Health (EVH) stake by 78% in Q1 2026, selling an estimated $1.7M and leaving 150,246 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

Deutsche Bank first reported a position in EVH in Q2 2015 and has held it in 44 quarters since. The position peaked at $12.5M in Q3 2018. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Deutsche Bank held 150,246 shares of Evolent Health worth $343K as of Q1 2026.
  • Deutsche Bank sold 536,319 Evolent Health shares in Q1 2026, an estimated $1.7M.
  • Evolent Health made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2765 holding.
  • Deutsche Bank first reported a position in Evolent Health in Q2 2015 and has held it in 44 quarters since.
  • Deutsche Bank's Evolent Health position peaked at $12.5M in Q3 2018.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.